Brenda Libby Coleman

Array ( [id] => 6637837 [patent_doc_number] => 20100173896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Organic Compounds' [patent_app_type] => utility [patent_app_number] => 12/724977 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13607 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173896.pdf [firstpage_image] =>[orig_patent_app_number] => 12724977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8516925 [patent_doc_number] => 20120316333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'PREPARATION METHOD OF DROSPIRENONE' [patent_app_type] => utility [patent_app_number] => 13/579229 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4121 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13579229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6620222 [patent_doc_number] => 20100310870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'AMORPHOUS BAZEDOXIFENE ACETATE AND PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/724432 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2759 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310870.pdf [firstpage_image] =>[orig_patent_app_number] => 12724432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8909462 [patent_doc_number] => 08481526 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Fluoroquinolone carboxylic acid molecular crystals' [patent_app_type] => utility [patent_app_number] => 12/723047 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 39 [patent_no_of_words] => 10904 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12723047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664466 [patent_doc_number] => 08377927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Compositions and methods for treatment of cancer' [patent_app_type] => utility [patent_app_number] => 12/722394 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 46581 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12722394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744884 [patent_doc_number] => 20120022250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'PROCESS FOR PREPARING CEPHALOTAXINE ESTERS' [patent_app_type] => utility [patent_app_number] => 13/255962 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7735 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022250.pdf [firstpage_image] =>[orig_patent_app_number] => 13255962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043823 [patent_doc_number] => 20120071649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'PROCESS FOR THE PREPARATION OF QUETIAPINE FUMARATE' [patent_app_type] => utility [patent_app_number] => 13/254416 [patent_app_country] => US [patent_app_date] => 2010-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6404 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071649.pdf [firstpage_image] =>[orig_patent_app_number] => 13254416 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663881 [patent_doc_number] => 20110313150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'CHIRAL DISULFONIMIDES' [patent_app_type] => utility [patent_app_number] => 13/203382 [patent_app_country] => US [patent_app_date] => 2010-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6199 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313150.pdf [firstpage_image] =>[orig_patent_app_number] => 13203382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663672 [patent_doc_number] => 20110312941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => '1,4-DISUBSTITUTED PIPERIDINES AS VASOPRESSIN RECEPTOR VIA ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/201054 [patent_app_country] => US [patent_app_date] => 2010-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43026 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312941.pdf [firstpage_image] =>[orig_patent_app_number] => 13201054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657325 [patent_doc_number] => 20110306594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => '1,4-BENZOTHIAZEPINE-1-OXIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION UTILIZING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/203188 [patent_app_country] => US [patent_app_date] => 2010-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8310 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306594.pdf [firstpage_image] =>[orig_patent_app_number] => 13203188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8028329 [patent_doc_number] => 08143244 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors' [patent_app_type] => utility [patent_app_number] => 12/710527 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40196 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143244.pdf [firstpage_image] =>[orig_patent_app_number] => 12710527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257850 [patent_doc_number] => 08207331 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Benzazepine derivatives for the treatment of neurological disorders' [patent_app_type] => utility [patent_app_number] => 12/707147 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37027 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12707147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663675 [patent_doc_number] => 20110312944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'Heterocyclic Compounds Which Modulate The CB2 Receptor' [patent_app_type] => utility [patent_app_number] => 13/147432 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30329 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312944.pdf [firstpage_image] =>[orig_patent_app_number] => 13147432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7791612 [patent_doc_number] => 20120053168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'FUSED BENZOAZEPINES AS NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS' [patent_app_type] => utility [patent_app_number] => 13/148385 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21316 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053168.pdf [firstpage_image] =>[orig_patent_app_number] => 13148385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7762466 [patent_doc_number] => 08114866 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-14 [patent_title] => 'Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme' [patent_app_type] => utility [patent_app_number] => 12/701897 [patent_app_country] => US [patent_app_date] => 2010-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11331 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/114/08114866.pdf [firstpage_image] =>[orig_patent_app_number] => 12701897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6136808 [patent_doc_number] => 20110009423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'PHENYL-PIPERAZINE DERIVATIVES AS SEROTONIN REUPTAKE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/700521 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7707 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009423.pdf [firstpage_image] =>[orig_patent_app_number] => 12700521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10888180 [patent_doc_number] => 08912176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-16 [patent_title] => 'Azetidines as histamine H3 receptor antagonists' [patent_app_type] => utility [patent_app_number] => 13/147337 [patent_app_country] => US [patent_app_date] => 2010-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38997 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13147337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6590641 [patent_doc_number] => 20100130483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'NOVEL DIAZABICYCLIC ARYL DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/694952 [patent_app_country] => US [patent_app_date] => 2010-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11976 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20100130483.pdf [firstpage_image] =>[orig_patent_app_number] => 12694952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7756880 [patent_doc_number] => 20120028968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'NOVEL DIBENZOFURANYL-OXADIAZOLYL-DIAZABICYCLONONANE DERIVATIVES AND THEIR MEDICAL USE' [patent_app_type] => utility [patent_app_number] => 13/146240 [patent_app_country] => US [patent_app_date] => 2010-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5963 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028968.pdf [firstpage_image] =>[orig_patent_app_number] => 13146240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744399 [patent_doc_number] => 20120022045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'BRIDGED COMPOUNDS AS HIV INTEGRASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/146595 [patent_app_country] => US [patent_app_date] => 2010-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40739 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022045.pdf [firstpage_image] =>[orig_patent_app_number] => 13146595 [rel_patent_id] =>[rel_patent_doc_number] =>)